Severe Hemophilia A: Clinical Trials

3 trials for Severe Hemophilia A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Terminated 1
Phase 12Active not recruiting 1, Terminated 1

Follow Severe Hemophilia A: new trials by email Literature Review of Severe Hemophilia A trials Research Report on Severe Hemophilia A

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A
GS1191-0445 injection - Severe Hemophilia A
Phase 1 / Phase 2Active not recruitingGritgen Therapeutics Co., Ltd.72023-07-102026-05-06
A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
FRSW117 - Severe Hemophilia A
Phase 2CompletedHangzhou Gensciences Biopharmaceutical Co., Ltd.152022-04-142023-05-15
Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A
OCTA101 - Severe Hemophilia A
Phase 1 / Phase 2TerminatedOctapharma362019-07-032026-10-15

Narrower conditions

Hemophilia A (3)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Coagulation Protein Disorders (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemorrhagic Disorders (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Blood Coagulation Disorders (2)  ·  Blood Coagulation Disorders, Inherited (2)  ·  Coagulation Protein Disorders (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemorrhagic Disorders (2)

Interventions

Injections (1)

Sponsors

Gritgen Therapeutics Co., Ltd. (1)  ·  Hangzhou Gensciences Biopharmaceutical Co., Ltd. (1)  ·  Octapharma (1)

Countries

China (2)  ·  Bulgaria (1)

Top investigators

Renchi Yang, PhD (1)